VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:VHI - CA92847V5018 - Common Stock
9.1 CAD
+0.02 (+0.22%)
Taking everything into account, VHI scores 6 out of 10 in our fundamental rating. VHI was compared to 8 industry peers in the Health Care Technology industry. VHI gets an excellent profitability rating and is at the same time showing great financial health properties. VHI is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make VHI suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year VHI was profitable.
VHI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: VHI reported negative net income in multiple years.
VHI had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
VHI has a better Return On Assets (0.76%) than 87.50% of its industry peers.
VHI has a Return On Equity of 1.08%. This is amongst the best in the industry. VHI outperforms 87.50% of its industry peers.
VHI has a better Return On Invested Capital (2.86%) than 100.00% of its industry peers.
VHI had an Average Return On Invested Capital over the past 3 years of 3.96%. This is in line with the industry average of 2.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROIC | 2.86% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
VHI's Profit Margin of 2.88% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
VHI has a better Operating Margin (12.47%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of VHI has grown nicely.
VHI has a better Gross Margin (80.92%) than 100.00% of its industry peers.
VHI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VHI is destroying value.
VHI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, VHI has more shares outstanding
The debt/assets ratio for VHI has been reduced compared to a year ago.
2.2 Solvency
VHI has an Altman-Z score of 3.83. This indicates that VHI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of VHI (3.83) is better than 62.50% of its industry peers.
VHI has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
VHI has a Debt to FCF ratio of 0.13. This is amongst the best in the industry. VHI outperforms 87.50% of its industry peers.
VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of VHI (0.00) is better than 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Altman-Z | 3.83 |
ROIC/WACC0.34
WACC8.47%
2.3 Liquidity
VHI has a Current Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.94, VHI is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
VHI has a Quick Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.94, VHI is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
The earnings per share for VHI have decreased strongly by -14.29% in the last year.
Looking at the last year, VHI shows a very strong growth in Revenue. The Revenue has grown by 59.34%.
Measured over the past years, VHI shows a very strong growth in Revenue. The Revenue has been growing by 46.32% on average per year.
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
3.2 Future
The Earnings Per Share is expected to grow by 78.88% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 27.14% on average over the next years. This is a very strong growth
EPS Next Y-2.2%
EPS Next 2Y99.19%
EPS Next 3Y78.88%
EPS Next 5YN/A
Revenue Next Year59.37%
Revenue Next 2Y38.13%
Revenue Next 3Y27.14%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 151.67 indicates a quite expensive valuation of VHI.
Compared to the rest of the industry, the Price/Earnings ratio of VHI indicates a rather cheap valuation: VHI is cheaper than 100.00% of the companies listed in the same industry.
VHI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.29.
A Price/Forward Earnings ratio of 32.76 indicates a quite expensive valuation of VHI.
87.50% of the companies in the same industry are more expensive than VHI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of VHI to the average of the S&P500 Index (23.51), we can say VHI is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 151.67 | ||
| Fwd PE | 32.76 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
VHI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VHI is cheaper than 87.50% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 47.14 | ||
| EV/EBITDA | 20.72 |
4.3 Compensation for Growth
VHI has a very decent profitability rating, which may justify a higher PE ratio.
VHI's earnings are expected to grow with 78.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y99.19%
EPS Next 3Y78.88%
5. Dividend
5.1 Amount
VHI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:VHI (12/9/2025, 7:00:00 PM)
9.1
+0.02 (+0.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners33.83%
Inst Owner ChangeN/A
Ins Owners11.38%
Ins Owner ChangeN/A
Market Cap574.39M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.33
Price Target15.51 (70.44%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.71%
Min EPS beat(2)-129.12%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-61.43%
Min EPS beat(4)-129.12%
Max EPS beat(4)-28.31%
EPS beat(8)0
Avg EPS beat(8)-58.34%
EPS beat(12)1
Avg EPS beat(12)-46.79%
EPS beat(16)2
Avg EPS beat(16)-54.73%
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)-1.47%
PT rev (3m)-2.08%
EPS NQ rev (1m)-15.79%
EPS NQ rev (3m)-14.29%
EPS NY rev (1m)-41.9%
EPS NY rev (3m)-49.32%
Revenue NQ rev (1m)3.74%
Revenue NQ rev (3m)4.53%
Revenue NY rev (1m)3.96%
Revenue NY rev (3m)7.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 151.67 | ||
| Fwd PE | 32.76 | ||
| P/S | 5.85 | ||
| P/FCF | 47.14 | ||
| P/OCF | 44.46 | ||
| P/B | 2.19 | ||
| P/tB | 11.67 | ||
| EV/EBITDA | 20.72 |
EPS(TTM)0.06
EY0.66%
EPS(NY)0.28
Fwd EY3.05%
FCF(TTM)0.19
FCFY2.12%
OCF(TTM)0.2
OCFY2.25%
SpS1.56
BVpS4.15
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROCE | 4.19% | ||
| ROIC | 2.86% | ||
| ROICexc | 4.95% | ||
| ROICexgc | N/A | ||
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% | ||
| FCFM | 12.41% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 7.67% | ||
| Cap/Sales | 0.75% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.17% | ||
| Profit Quality | 430.43% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 3.83 |
F-Score3
WACC8.47%
ROIC/WACC0.34
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y-2.2%
EPS Next 2Y99.19%
EPS Next 3Y78.88%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year59.37%
Revenue Next 2Y38.13%
Revenue Next 3Y27.14%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year75.9%
EBIT Next 3Y39.84%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
Can you provide the valuation status for VITALHUB CORP?
ChartMill assigns a valuation rating of 5 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
What are the PE and PB ratios of VITALHUB CORP (VHI.CA) stock?
The Price/Earnings (PE) ratio for VITALHUB CORP (VHI.CA) is 151.67 and the Price/Book (PB) ratio is 2.19.